Autor:	Chirag Dhar
Rok vydání:	2019
Předmět:	bepress\|Life Sciences bepress\|Life Sciences\|Immunology and Infectious Disease\|Other Immunology and Infectious Disease bepress\|Medicine and Health Sciences bepress\|Life Sciences\|Immunology and Infectious Disease
Popis:	Multiple case reports have been published on the risk of tuberculosis activation in patients on immune checkpoint inhibitors (ICPIs). To this matter, I caution clinicians to test for latent tuberculosis before starting their patients on ICPIs.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1077b130ff447dcbedaa7368cb9f907c https://indiarxiv.in/678kt Zobrazit plný text záznamu